Literature DB >> 8606709

Complications of intravenous gammaglobulin in neuromuscular and other diseases.

T E Bertorini1, A M Nance, L H Horner, W Greene, M S Gelfand, J H Jaster.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8606709     DOI： 10.1002/(SICI)1097-4598(199603)19:3<388::AID-MUS20>3.0.CO;2-N

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  14 in total

Review 1.  Adverse effects of intravenous immunoglobulin therapy.

Authors:  U E Nydegger; M Sturzenegger
Journal:  Drug Saf       Date:  1999-09       Impact factor: 5.606

2.  A prospective study of the immediate and delayed adverse events following intravenous immunoglobulin infusions.

Authors:  D Singh-Grewal; A Kemp; M Wong
Journal:  Arch Dis Child       Date:  2006-04-25       Impact factor: 3.791

Review 3.  Intravenous immunoglobulin: adverse effects and safe administration.

Authors:  Hedi Orbach; Uriel Katz; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

4.  Myasthenic crisis.

Authors:  Linda C Wendell; Joshua M Levine
Journal:  Neurohospitalist       Date:  2011-01

Review 5.  Intravenous immunoglobulin in neurological disease: a specialist review.

Authors:  C M Wiles; P Brown; H Chapel; R Guerrini; R A C Hughes; T D Martin; P McCrone; J Newsom-Davis; J Palace; J H Rees; M R Rose; N Scolding; A D B Webster
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

Review 6.  Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.

Authors:  Matthias Wittstock; Uwe K Zettl
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849

7.  Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis.

Authors:  Muthusamy Thiruppathi; Jian Rong Sheng; Liangcheng Li; Bellur S Prabhakar; Matthew N Meriggioli
Journal:  J Autoimmun       Date:  2014-01-02       Impact factor: 7.094

Review 8.  Intravenous immunoglobulin for Guillain-Barré syndrome.

Authors:  Richard A C Hughes; Anthony V Swan; Pieter A van Doorn
Journal:  Cochrane Database Syst Rev       Date:  2014-09-19

9.  Inflammatory Myopathy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.972

10.  Rasmussen's Encephalitis.

Authors:  Dianne Counce; Nita Limdi; Ruben Kuzniecky
Journal:  Curr Treat Options Neurol       Date:  2001-11       Impact factor: 3.972
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.